These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24269706)

  • 1. Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients.
    Issa NC; Marty FM; Leblebjian H; Galar A; Shea MM; Antin JH; Soiffer RJ; Baden LR
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):285-7. PubMed ID: 24269706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Aoki T; Koh K; Kawano Y; Mori M; Arakawa Y; Kato M; Hanada R
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):771-775. PubMed ID: 26748161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation.
    Sasadeusz J; Prince HM; Schwarer A; Szer J; Stork A; Bock HL; Povey M; Nicholson O; Innis BL
    Transpl Infect Dis; 2014 Dec; 16(6):1024-31. PubMed ID: 25272081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the duration of antiviral prophylaxis on rates of varicella-zoster virus reactivation disease in autologous hematopoietic cell transplantation recipients.
    Truong Q; Veltri L; Kanate AS; Hu Y; Craig M; Hamadani M; Cumpston A
    Ann Hematol; 2014 Apr; 93(4):677-82. PubMed ID: 24097085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella zoster virus meningoencephalitis after allogeneic hematopoietic stem cell transplantation.
    Suzuki J; Ashizawa M; Okuda S; Wada H; Sakamoto K; Terasako K; Sato M; Kimura SI; Kikuchi M; Nakasone H; Kako S; Yamazaki R; Oshima K; Nishida J; Kanda Y
    Transpl Infect Dis; 2012 Aug; 14(4):E7-12. PubMed ID: 22340704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation.
    Kawamura K; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Terasako K; Kimura S; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y
    Int J Infect Dis; 2014 Feb; 19():26-32. PubMed ID: 24211377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella zoster reactivation after hematopoietic stem cell transplant in children is strongly correlated with leukemia treatment and suppression of host T-lymphocyte immunity.
    Vermont CL; Jol-van der Zijde EC; Hissink Muller P; Ball LM; Bredius RG; Vossen AC; Lankester AC
    Transpl Infect Dis; 2014 Apr; 16(2):188-94. PubMed ID: 24438482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants.
    Hata A; Asanuma H; Rinki M; Sharp M; Wong RM; Blume K; Arvin AM
    N Engl J Med; 2002 Jul; 347(1):26-34. PubMed ID: 12097537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection.
    Alexander KE; Tong PL; Macartney K; Beresford R; Sheppeard V; Gupta M
    Vaccine; 2018 Jun; 36(27):3890-3893. PubMed ID: 29807711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults.
    Mullane KM; Winston DJ; Wertheim MS; Betts RF; Poretz DM; Camacho LH; Pergam SA; Mullane MR; Stek JE; Sterling TM; Zhao Y; Manoff SB; Annunziato PW
    J Infect Dis; 2013 Nov; 208(9):1375-85. PubMed ID: 23908479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Seropositivity after Live Attenuated Vaccine in Adult Patients Receiving Hematopoietic Stem Cell Transplantation.
    Aoki T; Kamimura T; Yoshida S; Mori Y; Kadowaki M; Kohno K; Ishihara D; Urata S; Sugio T; Kamezaki K; Kato K; Ito Y; Eto T; Akashi K; Miyamoto T
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1576-1585. PubMed ID: 30959161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of a live herpes zoster vaccine in hematopoietic stem cell transplant recipients.
    Chun JY; Kim K; Lee MK; Kang CK; Koh Y; Shin DY; Hong J; Choe PG; Kim NJ; Yoon SS; Park WB; Kim I; Oh MD
    BMC Infect Dis; 2021 Jan; 21(1):117. PubMed ID: 33499826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
    Distler E; Schnürer E; Wagner E; von Auer C; Plachter B; Wehler D; Huber C; Kolbe K; Meyer RG; Herr W
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live attenuated varicella vaccine.
    Arvin AM; Gershon AA
    Annu Rev Microbiol; 1996; 50():59-100. PubMed ID: 8905076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of vaccinating sibling donors with live-attenuated varicella zoster vaccine before hematopoietic stem cell transplantation.
    Leung AY; Chow HC; Kwok JS; Lui CK; Cheng VC; Yuen KY; Lie AK; Liang R
    Bone Marrow Transplant; 2007 Jun; 39(11):661-5. PubMed ID: 17417658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allotype analysis to distinguish the origin of varicella-zoster virus immunoglobulin G after allogeneic stem cell transplantation.
    Yamazaki R; Nakasone H; Tanaka Y; Sato M; Terasako K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Machishima T; Kimura S; Kikuchi M; Okuda S; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
    Biol Blood Marrow Transplant; 2013 Jul; 19(7):1013-20. PubMed ID: 23583826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella Zoster Virus Reactivation in Adult Survivors of Hematopoietic Cell Transplantation: How Do We Best Protect Our Patients?
    Lee CJ; Savani BN; Ljungman P
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1783-1787. PubMed ID: 29653205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic vaccination with a live-attenuated herpes zoster vaccine in lung transplant candidates.
    Wang L; Verschuuren EAM; Paap D; Rondaan C; Raveling-Eelsing E; Westra J; Bos NA
    J Heart Lung Transplant; 2020 Dec; 39(12):1445-1454. PubMed ID: 33071180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, tolerability, and immunogenicity of zoster vaccine in subjects on chronic/maintenance corticosteroids.
    Russell AF; Parrino J; Fisher CL; Spieler W; Stek JE; Coll KE; Su SC; Xu J; Li X; Schlienger K; Silber JL
    Vaccine; 2015 Jun; 33(27):3129-34. PubMed ID: 25964168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.